GlassScriptPhysician profile
Lance A Ellis
NPI 1508826074
$2,272.91
in general payments reported to CMS, 2019-2025
10 companies · $85.26 in 2025
The $85.26 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $751 · 2020: $1,000 · 2021: $195 · 2022: $228 · 2023: $13.51 · 2025: $85.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $98.77.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $98.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,201.47 | 2020-2022 | |
| Vertiflex, INC. | $516.52 | 2019 | |
| Stryker Corporation | $292.90 | 2019-2021 | |
| Si-Bone, INC. | $75.10 | 2019 | |
| Pylant Medical | $48.82 | 2022-2025 | |
| Relievant Medsystems, INC. | $45.55 | 2021 | |
| Depuy Synthes Sales INC. | $37.05 | 2025 | Trialtis |
| Pacira Pharmaceuticals Incorporated | $26.06 | 2025 | Exparel |
| Novo Nordisk INC | $15.93 | 2021 | |
| Integra Lifesciences Corporation | $13.51 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lance Ellis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.